Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Authors
Keywords
SARS-CoV-2, Stem cell therapy, ARDS, Immunomodulatory, Coronavirus
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 137, Issue -, Pages 111300
Publisher
Elsevier BV
Online
2021-01-29
DOI
10.1016/j.biopha.2021.111300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Lung Transplantation for Elderly Patients With End-Stage COVID-19 Pneumonia
- (2020) Weili Han et al. ANNALS OF SURGERY
- Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series
- (2020) Siddharth Singh et al. BASIC RESEARCH IN CARDIOLOGY
- Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis
- (2020) Jing-Yu Chen et al. CHINESE MEDICAL JOURNAL
- Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
- (2020) Vikram Sengupta et al. STEM CELLS AND DEVELOPMENT
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury
- (2020) Jiang Du et al. Stem Cell Research & Therapy
- Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
- (2020) Yingxin Zhang et al. Stem Cell Research & Therapy
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
- (2020) Hongbing Peng et al. Stem Cell Research & Therapy
- Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
- (2020) Kun Xiao et al. Stem Cell Research & Therapy
- Syndecan-2–positive, Bone Marrow–derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats
- (2018) Claire Masterson et al. ANESTHESIOLOGY
- Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats
- (2018) Xuxin Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo
- (2016) Michael C. W. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo
- (2016) Shuling Hu et al. Stem Cell Research & Therapy
- Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice
- (2015) Hirotaka Wakayama et al. CYTOTHERAPY
- Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat
- (2015) J. Devaney et al. THORAX
- In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
- (2015) Oscar E. Simonson et al. Stem Cells Translational Medicine
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli–induced acute lung injury in mice
- (2014) Sally M. Shalaby et al. CYTOTHERAPY
- Intratracheal Administration of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in a Patient with Acute Respiratory Distress Syndrome
- (2014) Youjin Chang et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- Introduction to Stem Cell Therapy
- (2013) Jesse K. Biehl et al. Journal of Cardiovascular Nursing
- Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury
- (2013) Shijia Zhang et al. Stem Cell Research & Therapy
- Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes
- (2011) Liang Peng et al. HEPATOLOGY
- Bone Marrow Derived Mesenchymal Stem Cells Inhibit Inflammation and Preserve Vascular Endothelial Integrity in the Lungs after Hemorrhagic Shock
- (2011) Shibani Pati et al. PLoS One
- Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
- (2009) M. Kumamoto et al. EUROPEAN RESPIRATORY JOURNAL
- Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells Engraftment on Bleomycin-Induced Lung Injury in Rats
- (2008) F. Zhao et al. TRANSPLANTATION PROCEEDINGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now